Regulatory Updates
Sep 22, 2026•1 min read
FDA Issues Tentative Approval for Atomoxetine Hydrochloride Capsules (ANDA078940)
The FDA has granted tentative approval for six oral capsule strengths of atomoxetine hydrochloride under ANDA078940, sponsored by Actavis Elizabeth.
Regulatory Updates
Sep 18, 2026•1 min read
FDA Grants ANDA Approval for Atomoxetine Capsules by Strides Pharma
The FDA approved ANDA 079021 for atomoxetine hydrochloride capsules from Strides Pharma Science, covering strengths from 10 mg to 100 mg.
1
Regulatory Updates
Sep 10, 2026•1 min read
FDA approves ANDA090609 for atomoxetine capsules by Dr. Reddy's Laboratories
FDA has granted approval for ANDA090609, allowing Dr. Reddy's Laboratories to market generic atomoxetine hydrochloride oral capsules in multiple strengths.